Company intelligence / Profile preview

Pegasus Mercantile

Vancouver, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

Pre-clinical and early clinical data indicate that AVM0703-induced gamma delta+ Natural Killer T-like cells could play a significant role in several diseases and conditions including diabetes and various forms of cancer[2].

Therapeutic areas: PsychiatryEndocrinologyNeurologyOncology
Modalities: Small moleculeSynthetic oligonucleotideNK cell therapy
Industry: Biotech

Partnerships

Biomed360 Solutions Corp. (BM360)AVM BiotechnologyBevteck Industries Inc.Independent Retailers Alliance Inc.

Beyond the preview

Go deeper on Pegasus Mercantile.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pegasus Mercantile.

Explore the full profile